Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Depreciation and Depletion: 2011-2024

Historic Depreciation and Depletion for OptimizeRx (OPRX) over the last 14 years, with FY2024 value amounting to $111000.0.

  • OptimizeRx's Depreciation and Depletion fell 270.08% to $1369.0 in Q1 2014 from the same period last year, while for Mar 2014 it was $5590.0, marking a year-over-year increase of 66.63%. This contributed to the annual value of $111000.0 for FY2024, which is 1100.0% up from last year.
  • OptimizeRx's Depreciation and Depletion amounted to $111000.0 in FY2024, which was up 1100.0% from $100000.0 recorded in FY2023.
  • In the past 5 years, OptimizeRx's Depreciation and Depletion ranged from a high of $111000.0 in FY2024 and a low of $85725.0 during FY2022
  • Over the past 5 years, OptimizeRx's median Depreciation and Depletion value was $100000.0 (recorded in 2023), while the average stood at $99457.4.
  • As far as peak fluctuations go, OptimizeRx's Depreciation and Depletion skyrocketed by 1869.69% in 2020, and later crashed by 1863.61% in 2022.
  • OptimizeRx's Depreciation and Depletion (Annual) stood at $95202.0 in 2020, then increased by 10.67% to $105360.0 in 2021, then decreased by 18.64% to $85725.0 in 2022, then grew by 16.65% to $100000.0 in 2023, then increased by 11.0% to $111000.0 in 2024.
  • Its Depreciation and Depletion stands at $111000.0 for FY2024, versus $100000.0 for FY2023 and $85725.0 for FY2022.